FIELD: physiology, pharmacology, medicinal chemistry. SUBSTANCE: invention relates to the improved method for inhibition of aggregation of platelets. The improved method involves inhibition of aggregation of platelets using sulfur- containing heterocyclic compounds, namely, using the known benzo-1,2-dithiol-3-thione or its derivatives of the general formula: wherein R1-R4 mean hydrogen atom or C1-4-alkyl. Invention provides the enhanced effectiveness for inhibition of aggregation of platelets under in vitro conditions. EFFECT: improved inhibition method. 2 ex
Title | Year | Author | Number |
---|---|---|---|
PLATELET AGGREGATION INHIBITOR SHOWING ANTIMETASTATIC EFFECT | 2001 |
|
RU2192857C1 |
PHARMACEUTICAL COMPOSITION, INCLUDING TRICYCLIC SULFUR-CONTAINING 1,2-DIHYDROQUINOLINE DERIVATIVE FOR INHIBITION OF REPLICATION OF BETA CORONAVIRUSES, INCLUDING SARS-CoV-2, AND METHOD OF ITS USE | 2021 |
|
RU2814434C1 |
METHOD OF PRODUCING A TRICYCLIC SULFUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING REPLICATION OF BETA-CORONAVIRUSES, INCLUDING SARS-CoV-2 | 2021 |
|
RU2819783C1 |
APPLICATION OF A TRICYCLIC SULPHUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780247C1 |
MEDICINAL PREPARATION POSSESSING ANTIAGGREGATE ACTIVITY | 1993 |
|
RU2039558C1 |
DERIVATIVES OF ANTHRA[2,1-D]ISOTHIAZOLE-3,6,11-TRIONE | 2002 |
|
RU2213744C1 |
AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
MATTER WITH ANTI-AGGREGATING ACTIVITY | 1993 |
|
RU2033158C1 |
2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
THROMBOCYTE AGGREGATION-INHIBITING N-CARB(ARGINYL)OXYMETHYLIMIDAZO[4,5-e]BENZO[1,2-c;3,4-c']DIFUROXANE | 2014 |
|
RU2549355C1 |
Authors
Dates
2004-04-10—Published
2002-10-23—Filed